Tyra Biosciences, Inc.

TYRA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$91,966$58,006$251,213$302,182
Short-Term Investments$249,475$145,463$0$0
Receivables$2,000$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$4,022$8,202$6,075$1,875
Total Curr. Assets$347,463$211,671$257,288$304,057
Property Plant & Equip (Net)$7,719$8,154$3,543$2,089
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$8,376$6,032$5,350$555
Total NC Assets$16,095$14,186$8,893$2,644
Other Assets$0$0$0$0
Total Assets$363,558$225,857$266,181$306,701
Liabilities
Payables$590$4,662$1,145$599
Short-Term Debt$412$280$140$202
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$13,592$10,391$4,416$2,815
Total Curr. Liab.$14,594$15,333$5,701$3,616
LT Debt$5,810$6,216$2,482$981
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3$46$169$367
Total NC Liab.$5,813$6,262$2,651$1,348
Other Liabilities$0$0$0$0
Cap. Leases$6,222$6,496$2,622$1,183
Total Liabilities$20,407$21,595$8,352$4,964
Equity
Pref Stock$0$0$0$0
Common Stock$5$4$4$4
Retained Earnings-$251,311-$164,830-$95,696-$40,371
AOCI$770$381$0$0
Other Equity$593,687$368,707$353,521$342,104
Total Equity$343,151$204,262$257,829$301,737
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$363,558$225,857$266,181$306,701
Net Debt-$85,744-$51,510-$248,591-$300,999